Besides *Aspergillus* and *Candida* species, which other molds fall under Voriconazole's approved indications?
Answer
*Scedosporium* and *Fusarium* species.
The clinical utility of voriconazole spans a broad spectrum of serious fungal pathogens, notably including various molds that cause invasive diseases. While its effectiveness against *Aspergillus* is a key feature, the approved indications also explicitly cover infections caused by certain other problematic molds. Specifically, serious infections caused by *Scedosporium* species and *Fusarium* species are included within the drug's established use profile. This broad spectrum ensures it remains a valuable option when patients suffer from systemic mycoses caused by these less common, yet highly virulent, fungal organisms, especially when other antifungals prove ineffective or are not tolerated.
Related Questions
How does Voriconazole primarily stop the growth of fungi?What severe infection is Voriconazole most notably recognized for treating?What is the recommended timing related to meals for the oral suspension?Which specific cytochrome P450 enzyme is cited for causing significant individual variability in Voriconazole metabolism?Why is Therapeutic Drug Monitoring (TDM) often required for Voriconazole therapy?How long do the transient visual disturbances associated with Voriconazole typically last?What mechanism underlies Voriconazole's potential for dangerous interactions with numerous other medications?Besides *Aspergillus* and *Candida* species, which other molds fall under Voriconazole's approved indications?When switching a stable patient between IV and oral Voriconazole routes, what dosage adjustment is generally maintained?For which common fungal infections is Voriconazole typically considered unsuitable due to its potency and side effect profile?